Inflammatory myopathies

Current Opinion in Neurology

Volumn 9, Issue 5, 1996, Pages 375-379

  Tews, Dominique S ^a   Goebel, Hans H ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CELL INCLUSION; CLINICAL FEATURE; FEMALE; HUMAN; MALE; MORPHOLOGY; MYOPATHY; MYOSITIS; POLYMYOSITIS; SEX DIFFERENCE; SHORT SURVEY;

EID: 0029966885     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199610000-00011     Document Type: Short Survey

References (29)

1. 4-cells infiltrating muscle tissue.
2. Smadja D, Bellance R, Cabre P, Arfi S, Vernant JC: Clinical characteristics of HTLV-1 associated dermato-polymyosltis - seven cases from Martinique. Acta Neurol Scand 1995, 92:206-212.
3. Tangy F, Vernant JC, Coscoy L, Ossondo M, Bellance R, Zaninovic V, Cartier L, Brahic M, Ozden S: A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis. Ann Neurol 1995, 38:454-460.
4. Sato K, Kamata T, Nakayama T, Kotera M, Akabane H: Acute bacterial myositis due to Staphylococcus aureus septicemia. Neurology 1995, 45:390-391.
5. Ilowite NT: Muscle, reticuloendothelial, and late skin manifestation of Lyme disease. Am J Med 1995, 98(suppl 4A):S63-S68.
6. Hall FC, Krausz T, Walport JM: Idiopathic eoslnophilic myositis. QJM - Mon J Assoc Physician 1995, 88:581-586.
7. + T cells. J Exp Med 1995, 181:1863-1868. This report provided greater insight in the autotoxic, T-cell-mediated muscle fibre damage in polymyositis by αβ T-cell receptor positive cells with a strictly limited T-cell receptor repertoire.
8. O'Hanlon TP, Messersmith WA, Dalakas MC, Plotz PH, Miller FW: Gamma • delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic Inflammatory myopathies. Clin Exp Immunol 1995, 100:519-528. The analysis of γδ T-cell receptor gene expression in inflammatory myopathies considers γδ T-cell receptor-positive cell infiltration as a secondary event, but not an active part of muscle fibre damage in autoimmune myositis.
9. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW: The alpha beta T-cell receptor repertoire in idiopathic inflammatory myopathies: distinct pattern of gene expression by muscle-infiltrating lymphocytes in different clinical and serologic groups. Ann N Y Acad Sci 1995, 756:410-413.
10. De Bleecker JL, Engel AG: Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 1995, 146:1178-1187.
11. Tews DS, Goebel HH: Expression of cell adhesion molecules in inflammatory myopathies. J Neuroimmunol 1995, 59:185-194.
12. Lindberg C, Oldfors A, Tarkowski A: Local T-cell proliferation and differentiation In inflammatory myopathies. Scand J Immunol 41:421-426.
13. Tews DS, Goebel HH: Cytoklne expression profile in idiopathic inflammatory • myopathies. J Neuropathol Exp Neurol 1996, 55:342-347. The first study of cytokine expression by muscle fibres in autoimmune myositis.
14. Martin A, Shulman MJ, Tsui FW: Epitope studies indicate that histidyl• tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J 1995,9:1226-1233. The authors give evidence that the anti-Jo-1 antibody is directed against epitopes of histidyl-tRNA synthetase and not against a crossreactive antigen.
15. Adams EM, Chow CK, Premkumar A, Plotz PH: The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics 1995, 15:563-574.
16. Swash M, Brown MM, Thakkar C: CT muscle imaging and the clinical assessment of neuromuscular disease. Muscle Nerve 1995, 18: 708-714.
17. Tanimoto K, Nakano K, Kano S, Mon S, Ueki H, Nishitani H, Sato T, Kiuchi T, Ohashi Y: Classification criteria for polymyositis and dermatomyositis [Comment]. J Rheumatol 1995, 22:668-674.
18. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN: Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 1995, 96:1730-1737.
19. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E: The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase Involved in transcriptional activation. Arthritis Rheum 1995, 38: 1398-1399.
20. Askanas V, Engel WK: New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Curr Opin Rheumatol 1995, 7:486-496.
21. Sherriff FE, Joachim CL, Squier MV, Esiri MM: Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin but not beta-amyloid. Neurosci Lett 1995, 194:35-38.
22. Harrington CR, Anderson JR, Chan KK: Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusionbody myositis. Neurosei Lett 1995, 183:35-38.
23. Oldfors A, Moslemi A-R, Fyhr I-M, Holme E, Larsson N-G, Lindberg C: • Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 1995, 54:581-587. A description of mitochondrial changes in inclusion body myositis with special emphasis on the mitochondrial defect known as 'common deletion'.
24. Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR: Inclusion body myositis: explanation for poor response to Immunosuppressive therapy. Neurology 1995, 45:1302-1304.
25. Pruitt II JN, Showaller CJ, Engel AG: Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 1996, 39: 139-143.
26. Tes DS, Pongratz DE: Immunohistological analysis of sarcoid myo• J Neurol Neurosurg Psychiatry 1995, 59:322-325. The first immunohistochemical analysis of distribution and subsets of inflammatory cells and antigen-expression of muscle fibres in granulomatous myositis.
27. Reichmann H, Schalke B, Seibel P, Naumann M, Toyka K: Sarcoid myopathy and mitochondrial respiratory chain defects: clinicopathological, biochemical and molecular biological analyses. Neuromusc Disord 1995, 5:277-283.
28. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW: Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995, 122:715-724.
29. Rider LG, Miller FW: Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol 1995, 2:1-9.